Evolocumab
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Evolocumab for coronary artery disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 2 |
| Evolocumab for coronary disease | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Evolocumab for hypercholesterolemia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Evolocumab for non-st elevated myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Evolocumab for st elevation myocardial infarction | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |